Research is sold on trials and kept on renewals
The trial is the sale, and most trials are never worked
Almost every research product is bought after a trial. A prospect asks for two weeks of the daily note, a sample initiating-coverage report, or access to the model portfolio. What happens next decides the revenue. In most firms, nothing happens next: the credentials are issued, the trial runs, and the only contact is an automated expiry email that arrives after the prospect has already stopped opening the notes.
Treating trials as a pipeline changes the behaviour, not the product. Each trial has a start date, an expiry countdown, an owner and a small number of scheduled touches: a call on day three to ask what they are looking at, a note on day seven tied to something the analyst published, a conversion conversation before expiry. HelloGrowthCRM keeps that sequence visible so a busy desk stops relying on remembering.
Renewals are quiet revenue that leaves quietly
Subscription research has a pleasant economic property and an unpleasant operational one. The pleasant property is that a renewed client costs almost nothing to serve. The unpleasant one is that a lapse produces no event: no complaint, no cancellation call, just an invoice that is never paid. A firm can lose fifteen per cent of its book in a year without a single difficult conversation.
A renewal calendar that surfaces expiries ninety days ahead, with the owner, the product and the last interaction attached, turns that silence into scheduled work. The conversation happens while the client is still engaged, which is also when the upgrade conversation is possible.